Dextofisopam
Alternative Names: (R)-tofisopam; Artofisopam; R-tofisopamLatest Information Update: 24 Jun 2011
At a glance
- Originator Vela Pharmaceuticals
- Developer Pharmos Corporation
- Class Antispasmodics; Anxiolytics; Benzodiazepines; Irritable bowel syndrome therapies; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes - Irritable bowel syndrome
Highest Development Phases
- Suspended Irritable bowel syndrome
Most Recent Events
- 28 Oct 2010 Dextofisopam is still available for licensing. www.pharmoscorp.com
- 14 Sep 2009 Efficacy and adverse events data from a Phase-II trial in Irritable bowel syndrome released by Pharmos Corporation
- 14 Sep 2009 Pharmos Corporation completes a Phase-IIb trial in Irritable bowel syndrome in USA